Background: Endothelial cells (ECs) make up the innermost layer throughout the entire 5 8 vasculature. Their phenotypes and physiological functions are initially regulated by 5 9 7 1 systematic analysis of the regulation and roles of HOX genes in mature tissue cells has 7 2 been lacking. These datasets provide a valuable resource for understanding the 7 3 vascular system and associated diseases.
INTRODUCTION 8 0
Endothelial cells (ECs), which make up the innermost blood vessel lining of the 2 4 2 located around known marker genes of ECs with chromatin loops. One example is 2 4 3 kinase insert domain receptor (KDR; Figure 2C , left), which functions as the VEGF example is intercellular adhesion molecule 2 (ICAM2, Figure 2C , right), which is an 2 4 9 endothelial marker and is involved in the binding to white blood cells that occurs during 2 5 0 the antigen-specific immune response (17) . This gene has two known TSSs, both of 2 5 1 which were annotated as active promoters in ECs, and one TSS that was EC specific 2 5 2 (black arrow). This EC-specific TSS did not have a ChIA-PET interaction, and, likewise, 2 5 3 the enhancer sites within the entire gene body did not directly interact with the adjacent 2 5 4 promoter sites, implying the distinctive regulation of the two ICAM2 promoters. To explore the correlation of EC-specific reference enhancer sites with 2 5 8 sequence variants associated with disease phenotypes, we obtained reference GWAS 2 5 9 single-nucleotide polymorphisms (SNPs) from the GWAS catalog (18) and identified 2 6 0 significantly enriched loci by permutation analysis (19) . Notably, we identified 67 2 6 1 enhancer sites that markedly overlapped with GWAS SNPs associated with "heart", 2 6 2 "coronary" and "cardiac" (Z score > 5.0, Supplementary Table S4 ). The most notable 2 6 3 region was around CALCRL and TFPI loci (chr2:188146468-188248446, Figure 2D ). The EC-specific enhancer region in these loci contained four GWAS risk variants disease (20, 21) . Another example is the RSPO3 locus (Supplementary Figure S4 ). The 2 6 7 1 0 upstream distal enhancer regions of that gene contained four GWAS SNPs that are 2 6 8 associated with cardiovascular disease and blood pressure (22, 23). We next investigated whether any characteristic sequence feature is observed in the 2 7 2 EC-specific enhancer and promoter sites (Supplementary Figure S5 ). We found a 2 7 3 putative motif for EC-specific enhancer sites, which is closely similar to the canonical 2 7 4 motifs of the homeobox genes bcd, oc, Gsc and PITX1,2,3 ( Figure 3 ). In fact, most of 2 7 5 the EC-specific enhancer sites consisted of enhancers of HGSVECs (47.0%), HRAECs 2 7 6 (37.4%) and HUAECs (68.3%) (Supplementary Figure S6 ), suggesting that these 2 7 7 enhancers contain this motif.
7 8
We also looked into the Gene Ontology (GO) classifications under Biological Process for the enhancer sites using GREAT (24) and found that the enhancer sites 2 8 0 (both all sites and EC-specific sites) have GO terms that are more specific to the 2 8 1 vascular system (e.g., platelet activation, myeloid leukocyte activation and 2 8 2 vasculogenesis), as compared with active promoter sites (e.g., mRNA catabolic process, Figure S7 ). This also suggests that the enhancer sites are more likely to 2 8 4 be associated with EC-specific functions, whereas promoter sites are also correlated 2 8 5 with the more common biological functions. One important issue of this study is to clarify the epigenomic/transcriptomic 2 8 9 diversity across EC cell types. To circumvent variances at the level of the individual in 2 9 0 each cell type observed ( Figure 2C ) and different S/N ratios, we fitted the value of peak 2 9 1 intensity on the reference enhancer sites among samples using generalized linear 2 9 2 models with the quantile normalization. By implementing a PCA, we confirmed that 2 9 3 different cell samples in the same EC type were properly clustered ( Figure 4A ). The PCA also showed that different EC types can be divided into two subgroups based on HCCaEC and HENDC, purple circle) and lower body (HUVEC, HUAEC, HGSVEC and 2 9 7 HRAEC) origins. A PCA based on gene expression data showed similar results to that 2 9 8 based on the H3K27ac profile, although in the gene expression analysis HUAECs were 2 9 9 1 1 more similar to heart ECs (Supplementary Figure S8 ). To further investigate this tendency, we implemented a multiple-group 3 0 1 differential analysis with respect to H3K4me3, H3K27ac and gene expression data to 3 0 2 obtain sites and genes whose values were significantly varied between any of the nine 3 0 3 cell types. With the threshold FDR < 1e-5, we identified 753 differential H3K4me3 sites 3 0 4 (differential promoters, DPs; 8.3% from 9,121 active promoter sites), 2,979 differential 3 0 5 H3K27ac sites (differential enhancers, DEs; 9.2% from 32,323 active promoter and We then implemented k-means clustering (k = 6) to characterize the overall = 6 was empirically defined and might not be biologically optimal to classify the nine EC 3 1 4 types, the results could capture the differential patterns. The upregulated genes were (cluster 3 of DP and DEG), consistent with the anatomical proximity of these ECs. HENDCs had uniquely expressed genes (cluster 6 of DEGs). Considering that most of 3 2 0 the DEGs and Des are cooperatively enriched in more than one EC type, these nine EC 3 2 1 types may use distinct combinations of multiple genes, rather than exclusively 3 2 2 expressed individual genes, for their specific phenotype. DEGs that contribute to EC functions 3 2 5
Our clustering analysis also identified important genes for EC functions as DEGs ( Figure 4B ). For example, heart and neural crest derivatives expressed 2 3 2 7 (HAND2) and GATA binding protein 4 (GATA4) were expressed in HAoECs, HENDCs and HPAECs (cluster 3). HAND2 physically interacts with GATA4 and the histone 3 2 9 acetyltransferase p300 to form the enhanceosome complex, which regulates 3 3 0 tissue-specific gene expression in the heart (25). Another example is hes related family 3 3 1 1 2 bHLH transcription factor with YRPW motif 2 (HEY2, also called Hrt2), a positive marker 3 3 2 for arterial EC specification (26), which was grouped to cluster 5 and was expressed 3 3 3 specifically in aorta-derived ECs but not in vein-derived ECs (HUVECs and HGSVECs). HRAECs showed uniquely upregulated genes, including cadherin 4 (CDH4); the protein 3 3 5 product of this gene mediates cell-cell adhesion, and mutation of this gene is 3 3 6 significantly associated with chronic kidney disease in the Japanese population (27). Interestingly, at TSSs of CDH4 and HEY2 loci, H3K4me3 was also enriched in some EC 3 3 8 types in which the genes were not expressed, whereas the H3K27ac enrichment pattern 3 3 9
at TSSs was correlated with the expression level ( Figure 4C ). This variation in
H3K4me3 with/without H3K27ac enrichment may reflect the competence of expression, 3 4 1 which cannot be fully captured by gene expression analysis. DEGs also contained several notable gene families. One example is the 3 4 3 claudin family, a group of transmembrane proteins involved in barrier and pore 3 4 4 formation (28). Whereas CLDN5 has been reported as a major constituent of the brain 3 4 5 EC tight junctions that make up the blood-brain barrier (29), we found that seven other 3 4 6 genes belonging to the claudin family (CLDN1, 7, 10, 11, 12, 14 and 15) were expressed 3 4 7
in ECs, and their expression pattern varied across EC types (Supplementary Figure   3 4 8 S11). For example, in HUVECs, CLDN11 was highly expressed but CLDN14 was not, 3 4 9 although the two claudins share a similar function for cation permeability (30). These DEGs are thus usable as a reference marker set for each EC type. Homeobox genes are highly differentially expressed across EC types 3 5 5
We also found that DEGs identified in our analysis contained genes that were 3 5 6 not previously acknowledged as relevant to the different EC types. Most strikingly, quite 3 5 7 a few homeobox (HOX) genes were differentially expressed (cluster 1 in Figure 4B HUAECs, but not in the upper-body ECs. More interestingly, perhaps, HOXD genes 3 6 7
were not expressed in HPAECs, despite their similar expression pattern relative to other 3 6 8 EC types around the heart ( Figure 4B ). This result implies the distinct use of HOX 3 6 9 paralogs, especially HOXD genes, in ECs. We also found that the 5' HOX genes (blue 3 7 0 bars in Figure 5A ) tended to be selectively expressed in EC types derived from the origin of EC types and that distinct activation of HOX genes collectively maintains the 3 7 5 diversity of the circulatory system. It has been suggested that the more 3' HOX genes tend to promote the 3 7 7 angiogenic phenotype in ECs, whereas the more 5' HOX genes tend to be inhibitory pro-angiogenic HOX genes (e.g., HOX3 paralogs), and thus human ECs that 3 8 2 overexpress HOXD10 fail to form new blood vessels (35). Figure 5A shows that 3 8 3 HOXD10 was highly expressed in HGSVECs, which evokes the inhibition of the 3 8 4 angiogenic phenotype as regulated by HOXD10 in this cell type. In addition to HOX genes, multiple non-HOX homeobox genes were also 3 8 6 differentially regulated across ECs. For example, cluster 3 in the DEGs contained NK2 3 8 7 homeobox 5 (Nkx-2.5), which is essential for maintenance of ventricular identity (36); both associated with the atrial fibrillation and cardioembolic ischemic stroke variants loci 3 9 0 (37-39); and Meis homeobox 1 (MEIS1), which is required for heart development in mice (40). These were all associated with the GO term "blood vessel morphogenesis 3 9 2 (GO:0048514)". Interestingly, PITX3 was mainly expressed in HENDCs (cluster 6), Gax; cluster 4), which regulates senescence and proliferation in HUVECs (41) and was 3 9 5 also expressed in HUAECs and HGSVECs but not in other cell types. Taken together 3 9 6 with the finding that some binding motifs of homeobox genes including PITX were 3 9 7 identified among the EC-specific enhancer sites (Figure 3) , these data suggest that Lastly, we investigated the epigenomic landscape around the HOXD cluster 4 0 4 ( Figure 5B ). It has been reported that the mammalian HOXD cluster is located between H3K27ac are specifically enriched within the HOXD10 locus in HGSVECs, which is ChIA-PET loops in HUVECs, there might be HGSVEC-specific chromatin loops. In this study, we analyzed the epigenomic status of the active histone compared with the smaller difference among EC types. To overcome these issues, at 4 3 2 least in part, we developed a robust procedure for comparative epigenome analysis, 4 3 3 combined with chromatin interaction data. We successfully identified 3,765 EC-specific 4 3 4 enhancer sites, 67 of which were highly significantly overlapping with GWAS SNPs. We 4 3 5 aim to expand this analysis to other core histone marks including suppressive markers 4 3 6 (e.g., H3K27me3 and H3K9me3) and apply semi-automated genome annotation 4 3 7 methods (45). Because this type of genome annotation strategy with its associated 4 3 8 assembling of broad marks is more sensitive to noise, more stringent quality control of 4 3 9 tissue data will be required. The PCA showed that EC types can be divided into those from the upper and 4 4 1 from the lower body ( Figure 4A ). The nine EC types tend to use distinct combinations of 4 4 2 multiple genes, rather than exclusively expressed genes, for their specific phenotype pathological conditions has been reported (46). However, a systematic analysis of the 4 4 7 regulation and roles of homeobox genes in mature tissue cells has been lacking. We The primary goal of the IHEC project is to generate high-quality reference 4 5 7 epigenomes and make them available to the scientific community (10). To this end, we ECs were isolated from the vasculature and maintained as primary cultures, as reduced concentration of VEGF that was lower than 5 ng/mL was tested in preliminary growth and viability (data not shown). The VEGF concentration was lowered to 250 4 7 5 pg/mL, which is lower than the standard culture conditions, to more closely replicate in expression values were then assembled to the gene-level by tximport (52). We also 5 0 7 obtained RNA-seq data from IMR90 cells from the Sequence Read Archive (SRA) For each EC sample, two million ECs were plated on a 15-cm culture plate and 5 1 4 cultured until confluency. The cells were crosslinked for 10 minutes using 1% Healthcare Bio-Sciences AB, Sweden). The prepared DNA was quantified using Qubit 5 2 2 (Life Technologies/Thermo Fisher Scientific), and >10 ng of DNA was processed, as 5 2 3 described below. The primer sequences for ChIP-qPCR were as follows: for H3K4me3, H3K27ac, ANGPTL4 (Fw: TAGGGGAATGGGTAGGGAAG, Rv: GGGCTGAGGGTTTGAAGTCC, Rv: CATGGTGTCTGTTTGAGGTTGC). were called by DROMPA version 3.5.1 (55) using the stringent parameter set (-sm 200 5 3 7 -pthre_internal 0.00001 -pthre_enrich 0.00001) to mitigate the effect of technical noise. 5 3 8
RNA-seq analysis
The mapping and peak statistics are summarized in Supplementary Table S2 . We checked the quality of each sample based on the peak number, library To estimate the expression level of a gene from the level of its histone 5 5 0 modifications, we implemented the linear regression analysis proposed by Karlic et al. (13) with minor modifications. We built a two-variable model to predict the expression 5 5 2 level for each mRNA as follows:
